GO
Loading...

Johnson & Johnson

More

  • Midday Glance: Pharmaceuticals companies Monday, 14 Apr 2014 | 2:08 PM ET

    Baxter International Inc. rose$. 79 or 1.1 percent, to $72.77. Bristol-Myers Squibb Co. fell$. 39 or. 8 percent, to $48.44. Hospira rose $1.35 or 3.2 percent, to $43.49.

  • Early Glance: Medical Devices companies Monday, 14 Apr 2014 | 10:21 AM ET

    Allergan rose$. 47 or. 4 percent, to $121.36. Baxter International Inc. rose$. 47 or. 7 percent, to $72.45. Boston Scientific Corp. rose$. 48 or 3.8 percent, to $13.17.

  • Early Glance: Pharmaceuticals companies Monday, 14 Apr 2014 | 10:21 AM ET

    Baxter International Inc. rose$. 47 or. 7 percent, to $72.45. Bristol-Myers Squibb Co. fell$. 07 or. 1 percent, to $48.77. Hospira rose$. 10 or. 2 percent, to $42.24.

  • US stocks recover some ground on retail sales gain Monday, 14 Apr 2014 | 9:13 AM ET

    But the market pushed higher from the get-go Monday, receiving a boost from solid earnings from Citigroup and a strong pickup in retail sales last month. Among the stocks that rose sharply were WebMD, Edwards Lifesciences and Goodrich Petroleum. Citigroup helped stoke the rally.

  • Early movers: C, MSFT, JNJ, LLY, V & more Monday, 14 Apr 2014 | 9:07 AM ET
    Traders on the floor of the New York Stock Exchange.

    These are the companies making headlines before the bell.

  • Last week's big stock selloff 'probably over': Pro Monday, 14 Apr 2014 | 8:37 AM ET
    Traders on the floor of the New York Stock Exchange on April 11, 2014

    The sharp stock market decline last week doesn't look like it will continue this week, Jonathan Golub, chief U.S. market strategist at RBC Capital, told CNBC on Monday.

  • Already turbulent markets face new turmoil Monday, 14 Apr 2014 | 6:36 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Like thunderstorms cooling an overheated landscape, more selling could rumble through the stock market in the coming week.

  • Why earnings will make or break the market this week Sunday, 13 Apr 2014 | 3:05 PM ET
    Traders on the floor of the New York Stock Exchange.

    Are earnings about to shrink? That's what analysts are expecting. And here's what that could mean for the market.

  • NEW YORK, April 13- The wrenching selloff in U.S. high-growth technology and biotech shares could leave investors braced for more than a minor pullback when earnings pick up speed this week.

  • "There's skepticism among investors about the outlook, and we're getting into the first-quarter earnings season, so you're going to see some positioning," said Brian Jacobsen, chief portfolio strategist at Wells Fargo Funds Management in Menomonee Falls, Wisconsin.

  • J&J says halting development of Botox rival Friday, 11 Apr 2014 | 6:17 PM ET

    Johnson & Johnson said on Friday it was ending its efforts to bring to market a rival drug to Allergan Inc's popular Botox anti-wrinkle treatment.

  • Final Glance: Pharmaceuticals companies Friday, 11 Apr 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $71.98. Bristol-Myers Squibb Co. fell$. 46 or. 9 percent, to $48.83. Hospira fell$. 58 or 1.4 percent, to $42.14.

  • Final Glance: Medical Devices companies Friday, 11 Apr 2014 | 6:03 PM ET

    Allergan rose $4.26 or 3.7 percent, to $120.89. Baxter International Inc. fell$. 28 or. 4 percent, to $71.98. Boston Scientific Corp. fell$. 24 or 1.9 percent, to $12.69.

  • Midday Glance: Pharmaceuticals companies Friday, 11 Apr 2014 | 1:51 PM ET

    Baxter International Inc. rose$. 15 or. 2 percent, to $72.41. Bristol-Myers Squibb Co. rose$. 07 or. 1 percent, to $49.36. Hospira fell$. 26 or. 6 percent, to $42.46.

  • Midday Glance: Medical Devices companies Friday, 11 Apr 2014 | 1:51 PM ET

    Allergan rose $4.38 or 3.8 percent, to $121.00. Baxter International Inc. rose$. 15 or. 2 percent, to $72.41. Boston Scientific Corp. fell$. 32 or 2.4 percent, to $12.62.

  • Squawking 'Miller' time, eBay's Icahn truce & Zell Thursday, 10 Apr 2014 | 4:14 PM ET

    It's Talking Squawk, the official "Squawk Box" blog, this week with Bill Miller on bitcoin, a truce between eBay and Carl Icahn, and Sam Zell on taxes.

  • What stocks are hot? Top picks from CNBC guests... Thursday, 10 Apr 2014 | 1:07 PM ET

    Ten leading money men and women have agreed to give investors access to their three best ideas this week. Here are the participants so far and their picks.

  • WASHINGTON, April 10- The leading U.S. pharmaceutical industry trade group on Thursday defended the cost of Gilead Sciences Inc's new hepatitis C drug, Sovaldi, saying such treatments offer a priceless breakthrough for patients with the liver-destroying virus.

  • Money managers give their healthiest stock picks Thursday, 10 Apr 2014 | 12:01 PM ET

    Money managers Martin Sass and Susan Byrne lay out their best stock picks in the "Squawk Box" Platinum Portfolio challenge. They like some health care companies.

  • Early Glance: Medical Devices companies Thursday, 10 Apr 2014 | 10:24 AM ET

    Allergan fell $1.17 or 1.0 percent, to $119.74. Baxter International Inc. fell$. 37 or. 5 percent, to $73.08. Boston Scientific Corp. fell$. 18 or 1.3 percent, to $13.36.

Most Popular Video

Thursday, 17 Apr 2014 | 4:13 PM ET

Dissecting today's market activity and the current state of financials, with Yra Harris, Praxis Trading partner; Larry Glazer, Mayflower Advisors; CNBC contributor Carol Roth; "Fast Money" Guy Adami and CNBC's Kate Kelly.

Thursday, 17 Apr 2014 | 5:46 PM ET

CNBC voice over talent Jim Birdsall shares the top 5 sayings from traders on "Fast Money" over the years.

Thursday, 17 Apr 2014 | 6:40 PM ET

Mad Money's Jim Cramer reflects on CNBC's evolution over the past 25 years.